BREAST CANCER DOES NOT INCREASE RISK OF COLORECTAL CANCERMarch 15, 2001Women with a history of breast cancer are not at an increased risk of colorectal cancer, conclude authors of a study published in this week's issue of THE LANCET. A history of breast cancer has been reported as a risk factor for colorectal cancer in women. However, in view of the ambiguous nature of existing evidence and the growing interest in targeted colorectal cancer prevention, Craig Newschaffer, from Johns Hopkins School of Hygiene and Public Health, Baltimore, USA, and colleagues sought to quantify this risk. The investigators estimated the risk of colorectal cancer after breast-cancer diagnosis in around 227 000 women with first incident breast cancer between 1974 and 1995. Observed colon and rectal cancer risk was compared with that expected in the general population. Comparisons were stratified by age at breast-cancer diagnosis, stage of cancer, ethnic origin of patient, and follow-up time. Women with previous breast cancer were 5% less likely to develop colon cancer and 13% less likely to develop rectal cancer than women in the general population. Stratification suggested that the risk reductions observed for colon and rectal cancer were most pronounced for women with breast cancer diagnosed after 65 years of age, in caucasian women, women with local stage breast cancer, and women diagnosed in the later study years (1990-94). Craig Newschaffer comments: "Our results suggest that breast-cancer history should not be thought of as a risk factor for colorectal cancer. We cannot explain the reduced risk for colorectal cancer that we noted in some groups of breast cancer patients, however, protection is unlikely to stem from endogenous biological factors. Patients or their physicians should not, however, misconstrue these findings - colorectal cancer is the third most common non-skin malignant disorder among women in the USA, and about 40% of those diagnosed die from the disease. Women with breast cancer, just as those without, should be encouraged to participate in colorectal-cancer screening and to make lifestyle choices likely to minimise colorectal-cancer risk". Contact: Tim Parsons or Ming Tai, Public Affairs, Johns Hopkins School of Hygiene & Public Health, 615 North Wolfe Street Room W1600, Baltimore MD 21205, USA; T) +1 410 955 6878; F) +1 410 955 4775; E) paffairs@jhsph.edu Lancet |
|||||||||||||||||||||
| Related Breast Cancer Current Events and Breast Cancer News Articles Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Fertility procedures need not delay breast cancer treatment for younger women A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Drugs to treat anemia in cancer patients linked to thromboembolism Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. Discovery in worms by Queen's researchers points to more targeted cancer treatment Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment. FDA approved leukemia drugs shows promise in ovarian cancer cells The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated. Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. Breast density associated with increased risk of cancer recurrence A new study finds that women treated for breast cancer are at higher risk of cancer recurrence if they have dense breasts. Published in the December 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study's results indicate that breast cancer patients with dense breasts may benefit from additional therapies following surgery, such as radiation. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||